Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

714 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intraindividual Variability in Serial Lipoprotein(a) Concentrations Among Placebo-Treated Patients in the OCEAN(a)-DOSE Trial.
Gaba P, Rosenson RS, López JAG, Watts GF, Leucker TM, Kuder JF, Im K, Kassahun H, Wang H, Wu Y, Wang J, Ohman EM, Sabatine MS, O'Donoghue ML. Gaba P, et al. Among authors: ohman em. J Am Coll Cardiol. 2024 Dec 4:S0735-1097(24)10043-5. doi: 10.1016/j.jacc.2024.10.081. Online ahead of print. J Am Coll Cardiol. 2024. PMID: 39665702 Free article. No abstract available.
Individual lifetime benefit from low-dose colchicine in patients with chronic coronary artery disease.
Burger PM, Dorresteijn JAN, Fiolet ATL, Koudstaal S, Eikelboom JW, Nidorf SM, Thompson PL, Cornel JH, Budgeon CA, Westendorp ICD, Beelen DPW, Martens FMAC, Steg PG, Asselbergs FW, Cramer MJ, Teraa M, Bhatt DL, Visseren FLJ, Mosterd A; LoDoCo2 Trial Investigators; UCC-SMART Study Group; REACH Registry Investigators. Burger PM, et al. Eur J Prev Cardiol. 2023 Dec 21;30(18):1950-1962. doi: 10.1093/eurjpc/zwad221. Eur J Prev Cardiol. 2023. PMID: 37409348
Impact of ticagrelor with or without aspirin on total and recurrent bleeding and ischemic events after percutaneous coronary intervention: A sub-study of the TWILIGHT trial.
Baber U, Cao D, Collier T, Sartori S, Dangas G, Angiolillo DJ, Vogel B, Kunadian V, Briguori C, Cohen DJ, Dudek D, Gibson CM, Gil R, Huber K, Kaul U, Kornowski R, Krucoff MW, Mehta S, Moliterno DJ, Ohman EM, Escaned J, Sardella G, Sharma SK, Shlofmitz R, Weisz G, Witzenbichler B, Steg PG, Pocock S, Mehran R. Baber U, et al. Among authors: ohman em. Eur Heart J Cardiovasc Pharmacother. 2024 Oct 17:pvae080. doi: 10.1093/ehjcvp/pvae080. Online ahead of print. Eur Heart J Cardiovasc Pharmacother. 2024. PMID: 39419783
The Use of Cangrelor in Cardiogenic Shock: Insights from the CAMEO Registry.
Rymer J, Pichan C, Page C, Alhanti B, Bhatt DL, Kochar A, Angiolillo DJ, Diaz M, Wimmer NJ, Waksman R, Ang L, Bach R, Jenkins R, El-Sabae H, Brothers L, Ohman EM, Jones WS, Washam JB, Wang TY, Narcisse D, Basir MB. Rymer J, et al. Among authors: ohman em. J Card Fail. 2024 Oct;30(10):1233-1240. doi: 10.1016/j.cardfail.2024.08.003. J Card Fail. 2024. PMID: 39389732
Risk of Bleeding Among Cangrelor-Treated Patients Administered Upstream P2Y12 Inhibitor Therapy: The CAMEO Registry.
Rymer J, Alhanti B, Kemp S, Bhatt DL, Kochar A, Angiolillo DJ, Diaz M, Garratt KN, Wimmer NJ, Waksman R, Kirtane AJ, Ang L, Bach R, Barker C, Jenkins R, Basir MB, Sullivan A, El-Sabae H, Brothers L, Ohman EM, Jones WS, Washam JB, Wang TY. Rymer J, et al. Among authors: ohman em. J Soc Cardiovasc Angiogr Interv. 2023 Nov 27;3(2):101202. doi: 10.1016/j.jscai.2023.101202. eCollection 2024 Feb. J Soc Cardiovasc Angiogr Interv. 2023. PMID: 39132213 Free PMC article.
Angiogenic Gene Therapy for Refractory Angina: Results of the EXACT Phase 2 Trial.
Nakamura K, Henry TD, Traverse JH, Latter DA, Mokadam NA, Answini GA, Williams AR, Sun BC, Burke CR, Bakaeen FG, DiCarli MF, Chaitman BR, Peterson MW, Byrnes DG, Ohman EM, Pepine CJ, Crystal RG, Rosengart TK, Kowalewski E, Koch GG, Dittrich HC, Povsic TJ; EXACT Trial Investigators. Nakamura K, et al. Among authors: ohman em. Circ Cardiovasc Interv. 2024 May;17(5):e014054. doi: 10.1161/CIRCINTERVENTIONS.124.014054. Epub 2024 May 2. Circ Cardiovasc Interv. 2024. PMID: 38696284 Free PMC article. Clinical Trial.
Hypertension, microvascular obstruction and infarct size in patients with STEMI undergoing PCI: Pooled analysis from 7 cardiac magnetic resonance imaging studies.
Mehdipoor G, Redfors B, Chen S, Gkargkoulas F, Zhang Z, Patel MR, Granger CB, Ohman EM, Maehara A, Eitel I, Ben-Yehuda O, de Waha-Thiele S, Thiele H, Stone GW. Mehdipoor G, et al. Among authors: ohman em. Am Heart J. 2024 May;271:148-155. doi: 10.1016/j.ahj.2024.02.023. Epub 2024 Mar 1. Am Heart J. 2024. PMID: 38430992
Dyspnea-Related Ticagrelor Discontinuation After Percutaneous Coronary Intervention.
Angiolillo DJ, Cao D, Sartori S, Baber U, Dangas G, Zhang Z, Vogel B, Kunadian V, Briguori C, Cohen DJ, Collier T, Dudek D, Gibson M, Gil R, Huber K, Kaul U, Kornowski R, Krucoff MW, Ielasi A, Stefanini GG, Pivato CA, Mehta S, Moliterno DJ, Ohman EM, Escaned J, Sardella G, Sharma SK, Shlofmitz R, Weisz G, Witzenbichler B, Steg PG, Pocock S, Mehran R. Angiolillo DJ, et al. Among authors: ohman em. JACC Cardiovasc Interv. 2023 Oct 23;16(20):2514-2524. doi: 10.1016/j.jcin.2023.08.019. JACC Cardiovasc Interv. 2023. PMID: 37879803 Free article. Clinical Trial.
Bleeding and Ischemic Risks of Ticagrelor Monotherapy After Coronary Interventions.
Mendieta G, Mehta S, Baber U, Angiolillo DJ, Briguori C, Cohen D, Collier T, Dangas G, Dudek D, Escaned J, Gil R, Vogel B, Cao D, Spirito A, Huber K, Kastrati A, Kaul U, Kornowski R, Krucoff MW, Kunadian V, Moliterno DJ, Ohman EM, Sardella G, Sartori S, Sharma S, Shlofmitz R, Steg PG, Han YL, Pocock S, Gibson CM, Mehran R. Mendieta G, et al. Among authors: ohman em. J Am Coll Cardiol. 2023 Aug 22;82(8):687-700. doi: 10.1016/j.jacc.2023.05.062. J Am Coll Cardiol. 2023. PMID: 37587580 Free article. Clinical Trial.
714 results